<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23175376</PMID><DateCompleted><Year>2013</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture.</ArticleTitle><Pagination><StartPage>1759</StartPage><EndPage>1769</EndPage><MedlinePgn>1759-69</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02139-12</ELocationID><Abstract><AbstractText>It has been shown in animal models that ribavirin-resistant poliovirus with a G64S mutation in its 3D polymerase has high replication fidelity coupled with attenuated virulence. Here, we describe the effects of mutagenesis in the human enterovirus 71 (HEV71) 3D polymerase on ribavirin resistance and replication fidelity. Seven substitutions were introduced at amino acid position 3D-G64 of a HEV71 full-length infectious cDNA clone (26M). Viable clone-derived virus populations were rescued from the G64N, G64R, and G64T mutant cDNA clones. The clone-derived G64R and G64T mutant virus populations were resistant to growth inhibition in the presence of 1,600 &#x3bc;M ribavirin, whereas the growth of parental 26M and the G64N mutant viruses were inhibited in the presence of 800 &#x3bc;M ribavirin. Nucleotide sequencing of the 2C and 3D coding regions revealed that the rate of random mutagenesis after 13 passages in the presence of 400 &#x3bc;M ribavirin was nearly 10 times higher in the 26M genome than in the mutant G64R virus genome. Furthermore, random mutations acquired in the 2C coding regions of 26M and G64N conferred resistance to growth inhibition in the presence of 0.5 mM guanidine, whereas the G64R and G64T mutant virus populations remained susceptible to growth inhibition by 0.5 mM guanidine. Interestingly, a S264L mutation identified in the 3D coding region of 26M after ribavirin selection was also associated with both ribavirin-resistant and high replication fidelity phenotypes. These findings are consistent with the hypothesis that the 3D-G64R, 3D-G64T, and 3D-S264L mutations confer resistance upon HEV71 to the antiviral mutagen ribavirin, coupled with a high replication fidelity phenotype during growth in cell culture.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadeghipour</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Diseases and Immunology, Sydney Medical School, University of Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bek</LastName><ForeName>Emily J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>McMinn</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>KC118542</AccessionNumber><AccessionNumber>KC118543</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>49717AWG6K</RegistryNumber><NameOfSubstance UI="D012254">Ribavirin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.6</RegistryNumber><NameOfSubstance UI="D012321">DNA-Directed RNA Polymerases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012321" MajorTopicYN="N">DNA-Directed RNA Polymerases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024882" MajorTopicYN="Y">Drug Resistance, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059645" MajorTopicYN="N">Mutation Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012254" MajorTopicYN="N">Ribavirin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012692" MajorTopicYN="N">Serial Passage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23175376</ArticleId><ArticleId IdType="pmc">PMC3554166</ArticleId><ArticleId IdType="doi">10.1128/JVI.02139-12</ArticleId><ArticleId IdType="pii">JVI.02139-12</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129:304&#x2013;309</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341:929&#x2013;935</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91&#x2013;107</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen JL, Long AM, Schultz SC. 1997. Structure of the RNA-dependent RNA polymerase of poliovirus. Structure 5:1109&#x2013;1122</Citation><ArticleIdList><ArticleId IdType="pubmed">9309225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok CC, McMinn PC. 2009. Picornavirus RNA-dependent RNA polymerase. Int. J. Biochem. Cell Biol. 41:498&#x2013;502</Citation><ArticleIdList><ArticleId IdType="pubmed">18487072</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P, Peersen OB. 2010. Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 107:22505&#x2013;22510</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3012486</ArticleId><ArticleId IdType="pubmed">21148772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Lou Z, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li X, Rao Z. 2010. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell 1:491&#x2013;500</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4875138</ArticleId><ArticleId IdType="pubmed">21203964</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignuzzi M, Stone JK, Andino R. 2005. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res. 107:173&#x2013;181</Citation><ArticleIdList><ArticleId IdType="pubmed">15649563</ArticleId></ArticleIdList></Reference><Reference><Citation>Graci JD, Cameron CE. 2006. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 16:37&#x2013;48</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169142</ArticleId><ArticleId IdType="pubmed">16287208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer JK, Kirkegaard K. 2003. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. U. S. A. 100:7289&#x2013;7294</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165868</ArticleId><ArticleId IdType="pubmed">12754380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, Wang J, Zhang C, Cao Q, Deng Y, Hu W, Yao K. 2012. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch. Virol. 157:669&#x2013;679</Citation><ArticleIdList><ArticleId IdType="pubmed">22245989</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Cameron C, Andino R. 2002. Ribavirin's antiviral mechanism of action: lethal mutagenesis? J. Mol. Med. (Berl.) 80:86&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pubmed">11907645</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Maag D, Arnold JJ, Zhong W, Lau JY, Hong Z, Andino R, Cameron CE. 2000. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:1375&#x2013;1379</Citation><ArticleIdList><ArticleId IdType="pubmed">11100123</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold JJ, Vignuzzi M, Stone JK, Andino R, Cameron CE. 2005. Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J. Biol. Chem. 280:25706&#x2013;25716</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1557591</ArticleId><ArticleId IdType="pubmed">15878882</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignuzzi M, Wendt E, Andino R. 2008. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 14:154&#x2013;161</Citation><ArticleIdList><ArticleId IdType="pubmed">18246077</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus SE, Diamond DC, Emini EA, Wimmer E. 1986. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J. Virol. 57:638&#x2013;646</Citation><ArticleIdList><ArticleId IdType="pmc">PMC252779</ArticleId><ArticleId IdType="pubmed">3003395</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua BH, Phuektes P, Sanders SA, Nicholls PK, McMinn PC. 2008. The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89:1622&#x2013;1632</Citation><ArticleIdList><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. 2001. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in western Australia. Clin. Infect. Dis. 32:236&#x2013;242</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27:493&#x2013;497</Citation></Reference><Reference><Citation>Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344&#x2013;348</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569948</ArticleId><ArticleId IdType="pubmed">16327776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus SE, Rohl H, Wimmer E. 1987. Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology 157:83&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pubmed">3029969</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghipour S, Bek EJ, McMinn PC. 2012. Selection and characterisation of guanidine-resistant mutants of human enterovirus 71. Virus Res. 169:72&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">22814431</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsham GJ, Normann P. 2008. Dynamics of picornavirus RNA replication within infected cells. J. Gen. Virol. 89:485&#x2013;493</Citation><ArticleIdList><ArticleId IdType="pubmed">18198379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TR, Cisnetto V, Bose D, Bailey M, Wilson JR, Zhang X, Belsham GJ, Curry S. 2010. Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism. J. Biol. Chem. 285:24347&#x2013;24359</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2915670</ArticleId><ArticleId IdType="pubmed">20507978</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins RK, Revankar GR, McKernan PA, Murray BK, Kirsi JJ, North JA. 1985. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin. Adv. Enzyme Regul. 24:29&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">2872781</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RA, Kirkpatrick W. (ed). 1980. Ribavirin: a broad spectrum antiviral agent. Academic Press, Inc., San Diego, CA</Citation></Reference><Reference><Citation>Streeter DG, Witkowski JT, Khare GP, Sidwell RW, Bauer RJ, Robins RK, Simon LN. 1973. Mechanism of action of 1-&#x3b2;-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad-spectrum antiviral agent. Proc. Natl. Acad. Sci. U. S. A. 70:1174&#x2013;1178</Citation><ArticleIdList><ArticleId IdType="pmc">PMC433451</ArticleId><ArticleId IdType="pubmed">4197928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, Rassam S, Fryden A, Reesink H, Bassendine M, Norkrans G, Cuypers T, Lelie N, Telfer P, Watson J, Weegink C, Sillikens P, Weiland O. 1996. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J. Hepatol. 25:591&#x2013;598</Citation><ArticleIdList><ArticleId IdType="pubmed">8938532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultgren C, Milich DR, Weiland O, Sallberg M. 1998. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J. Gen. Virol. 79:2381&#x2013;2391</Citation><ArticleIdList><ArticleId IdType="pubmed">9780043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosmann TR, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">8820272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam RC, Ramasamy K, Bard J, Pai B, Lim C, Averett DR. 2000. The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels. Antimicrob. Agents Chemother. 44:1276&#x2013;1283</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89855</ArticleId><ArticleId IdType="pubmed">10770762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman TP, Deeprose RD. 1978. Metabolism of 5-amino-1-&#x3b2;-d-ribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5&#x2032;-triphosphates in human blood and L5178Y cells. Biochem. Pharmacol. 27:709&#x2013;716</Citation><ArticleIdList><ArticleId IdType="pubmed">207278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Agudo R, Domingo E, Verdaguer N. 2009. Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase. Curr. Opin. Struct. Biol. 19:752&#x2013;758</Citation><ArticleIdList><ArticleId IdType="pubmed">19914060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Orta C, Arias A, Agudo R, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N. 2006. The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J. 25:880&#x2013;888</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1383552</ArticleId><ArticleId IdType="pubmed">16456546</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Weng L, Zhang N, Arita M, Li R, Chen L, Toyoda T. 2011. Biochemical characterization of enterovirus 71 3D RNA polymerase. Biochim. Biophys. Acta 1809:211&#x2013;219</Citation><ArticleIdList><ArticleId IdType="pubmed">21220056</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AA, Peersen OB. 2004. Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J. 23:3462&#x2013;3471</Citation><ArticleIdList><ArticleId IdType="pmc">PMC516629</ArticleId><ArticleId IdType="pubmed">15306852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gn&#xe4;dig NF, Beaucourt S, Campagnola G, Border&#xed;a AV, Sanz-Ramos M, Gong P, Blanc H, Peersen OB, Vignuzzi M. 2012. Coxsackievirus B3 mutator strains are attenuated in vivo. Proc. Natl. Acad. Sci. U. S. A. 109:E2294&#x2013;E2303</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427060</ArticleId><ArticleId IdType="pubmed">22853955</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohara DW, Crotty S, Arnold JJ, Yoder JD, Andino R, Cameron CE. 2000. Poliovirus RNA-dependent RNA polymerase (3Dpol): structural, biochemical, and biological analysis of structural motifs A and B. J. Biol. Chem. 275:25523&#x2013;25532</Citation><ArticleIdList><ArticleId IdType="pubmed">10827187</ArticleId></ArticleIdList></Reference><Reference><Citation>Styczynski MP, Jensen KL, Rigoutsos I, Stephanopoulos G. 2008. BLOSUM62 miscalculations improve search performance. Nat. Biotechnol. 26:274&#x2013;275</Citation><ArticleIdList><ArticleId IdType="pubmed">18327232</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>